Two patents have been awarded to the UA based on the novel approach of ProNeurogen to treating diseases causing memory loss and cognitive impairment. BIO5 Institute member Meredith Hay started ProNeurogen Inc., a company based on inventions rising out of research in neuroscience and cardiovascular neurophysiology.
Related
